Neuropsychopharmacology of the regulation of DA neuronal function, (i.e. control of DA release/reuptake into the presynaptic terminal, metabolism of DA, of dopamine (DA) functional responses induced by DA receptor stimulation, and the development of novel treatments for diseases involving DA pathophysiology, (i.e., Parkinson`s disease, schizophrenia and drug abuse)